Philadelphia-chromosome-negative peripheral blood stem cells can be mobilized in the early phase of recovery after a myelosuppressive chemotherapy in Philadelphia-chromosome-positive acute lymphoblastic leukaemia
- 1 March 1995
- journal article
- clinical trial
- Published by Wiley in British Journal of Haematology
- Vol. 89 (3) , 535-538
- https://doi.org/10.1111/j.1365-2141.1995.tb08360.x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Intensive chemotherapy for Philadelphia-chromosome-positive acute lymphoblastic leukaemiaThe Lancet, 1994
- Chimeric BCR-abl messenger RNA as a marker for minimal residual disease in patients transplanted for Philadelphia chromosome-positive acute lymphoblastic leukemiaBlood, 1991
- Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemiaBlood, 1991
- Importance of Long-Term Follow-up in Evaluating Treatment Regimens for Adults with Acute Lymphoblastic LeukemiaPublished by Springer Nature ,1990
- Competition between recipient and donor cells after bone marrow transplantation for chronic myeloid leukaemiaBritish Journal of Haematology, 1988
- Correlation of karyotype and immunophenotype in childhood acute lymphoblastic leukemia.Journal of Clinical Oncology, 1988
- Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adultsBlood, 1988